Cresilon Receives First FDA Clearance For Human Use of Hemostatic Gel Technology
Legacy MEDSearch
JUNE 30, 2023
Food and Drug Administration (“FDA”) for Cresilon Hemostatic Gel (“CHG ”). ” CHG leverages Cresilon’s in-house manufacturing capabilities, advanced engineering, and focused research teams. CHG is for prescription use only.
Let's personalize your content